发布求助
文献互助 智能选刊 最新文献

Actualites Pharmaceutiques最新文献

筛选
英文 中文
Impulsion, un dispositif d’oncologie intégrative au cœur du territoire “冲动”（Impulsion），一个位于法国心脏地带的综合性肿瘤学设备
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-07-25 DOI: 10.1016/j.actpha.2025.05.013
Jérôme Sicard (Docteur en pharmacie) , Mohammed Lamdaoir (Docteur en pharmacie)
{"title":"Impulsion, un dispositif d’oncologie intégrative au cœur du territoire","authors":"Jérôme Sicard (Docteur en pharmacie) ,&nbsp;Mohammed Lamdaoir (Docteur en pharmacie)","doi":"10.1016/j.actpha.2025.05.013","DOIUrl":"10.1016/j.actpha.2025.05.013","url":null,"abstract":"<div><div>Le dispositif Impulsion permet, pendant et après un cancer, à 200 personnes de bénéficier, à moindres frais et au plus près de leur lieu de vie, d’un suivi personnalisé en oncologie intégrative sélectionné parmi neuf soins. L’objectif est d’assurer à tous les patients un égal accès aux compétences locales en complément de la prise en soins proposée au sein des établissements de santé.</div></div><div><div>The Impulsion program enables 200 people, during and after cancer, to benefit from personalized, low-cost integrative oncology care selected from nine different treatments, as close as possible to where they live. The aim is to ensure that all patients have equal access to local expertise, as a complement to the care offered in healthcare establishments.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 648","pages":"Pages 40-45"},"PeriodicalIF":0.1,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144702758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dépistage et suivi des traitements de la DMLA DMLA治疗的检测和监测
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-07-25 DOI: 10.1016/j.actpha.2025.05.017
Jean-Michel Mrozovski (Président d’honneur de la Coopération pour la valorisation de l’acte officinal (CVAO))
{"title":"Dépistage et suivi des traitements de la DMLA","authors":"Jean-Michel Mrozovski (Président d’honneur de la Coopération pour la valorisation de l’acte officinal (CVAO))","doi":"10.1016/j.actpha.2025.05.017","DOIUrl":"10.1016/j.actpha.2025.05.017","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 648","pages":"Pages 59-61"},"PeriodicalIF":0.1,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144702762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
profession 职业
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-07-25 DOI: 10.1016/j.actpha.2025.07.018
{"title":"profession","authors":"","doi":"10.1016/j.actpha.2025.07.018","DOIUrl":"10.1016/j.actpha.2025.07.018","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 648","pages":"Page 4"},"PeriodicalIF":0.1,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144702829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Un syndrome anticholinergique 抗胆碱能综合症
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-07-25 DOI: 10.1016/j.actpha.2025.05.007
Samuel Legeay (Maître de conférences des universités), Sébastien Faure (Professeur des universités)
{"title":"Un syndrome anticholinergique","authors":"Samuel Legeay (Maître de conférences des universités),&nbsp;Sébastien Faure (Professeur des universités)","doi":"10.1016/j.actpha.2025.05.007","DOIUrl":"10.1016/j.actpha.2025.05.007","url":null,"abstract":"<div><div>Une ordonnance complexe peut regrouper plusieurs médicaments à potentiel anticholinergique qui sont susceptibles de s’accumuler et de favoriser les syndromes gériatriques qui comprennent des troubles cognitifs et fonctionnels. Les charges anticholinergiques centrales et périphériques peuvent être calculées à l’aide d’échelles validées. L’analyse pharmaceutique de l’ordonnance permettra au pharmacien d’officine d’évaluer la charge anticholinergique du traitement et de proposer au médecin prescripteur des alternatives thérapeutiques afin de la diminuer et de limiter ses impacts cliniques.</div></div><div><div>A complex prescription may group together several drugs with anticholinergic potential, which are likely to accumulate and promote geriatric syndromes that include cognitive and functional impairment. Central and peripheral anticholinergic loads can be calculated using validated scales. Pharmaceutical analysis of the prescription will enable the dispensing pharmacist to assess the anticholinergic load of the treatment and suggest therapeutic alternatives to the prescribing physician in order to reduce it and limit its clinical impact.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 648","pages":"Pages 15-17"},"PeriodicalIF":0.1,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144702839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
santé publique 公共卫生
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-07-25 DOI: 10.1016/j.actpha.2025.07.019
{"title":"santé publique","authors":"","doi":"10.1016/j.actpha.2025.07.019","DOIUrl":"10.1016/j.actpha.2025.07.019","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 648","pages":"Page 5"},"PeriodicalIF":0.1,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144702764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Les immunothérapies, bénéfices et risques 免疫疗法的好处和风险
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-07-25 DOI: 10.1016/j.actpha.2025.05.010
Eurydice Angeli (Oncologue médical, PHD)
{"title":"Les immunothérapies, bénéfices et risques","authors":"Eurydice Angeli (Oncologue médical, PHD)","doi":"10.1016/j.actpha.2025.05.010","DOIUrl":"10.1016/j.actpha.2025.05.010","url":null,"abstract":"<div><div>L’immunothérapie est une véritable révolution thérapeutique, largement prescrite aujourd’hui en oncologie. Cependant, il est important de rapidement identifier les effets indésirables auto-immuns qu’elle est susceptible d’engendrer.</div></div><div><div>Immunotherapy is a genuine therapeutic revolution, widely prescribed in oncology today. However, it is important to quickly identify the autoimmune side effects it can cause.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 648","pages":"Pages 22-26"},"PeriodicalIF":0.1,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144702570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glaucome chronique et glaucome aigu, deux pathologies oculaires invalidantes 慢性青光眼和急性青光眼，两种使人衰弱的眼病
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-07-01 DOI: 10.1016/j.actpha.2025.05.020
Damien Malbos (Docteur en pharmacie)
{"title":"Glaucome chronique et glaucome aigu, deux pathologies oculaires invalidantes","authors":"Damien Malbos (Docteur en pharmacie)","doi":"10.1016/j.actpha.2025.05.020","DOIUrl":"10.1016/j.actpha.2025.05.020","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 648","pages":"Page 7"},"PeriodicalIF":0.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144702387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Un patient pressé, non réceptif 急躁的病人
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-07-01 DOI: 10.1016/j.actpha.2025.05.027
Guillemine Dubois (Docteure en pharmacie, directrice de l’ANFPP) , Stéphane Kieny (Responsable des relations externes UPSA, partenaire de l’ANFPP)
{"title":"Un patient pressé, non réceptif","authors":"Guillemine Dubois (Docteure en pharmacie, directrice de l’ANFPP) ,&nbsp;Stéphane Kieny (Responsable des relations externes UPSA, partenaire de l’ANFPP)","doi":"10.1016/j.actpha.2025.05.027","DOIUrl":"10.1016/j.actpha.2025.05.027","url":null,"abstract":"<div><div>Chaque personne qui entre dans une pharmacie est singulière, du fait de son histoire personnelle et médicale, de son caractère ou de ses préoccupations. Les membres de l’équipe officinale doivent savoir adapter leur attitude et leur discours à chacun. L’objectif est de délivrer médicaments et conseils dans les meilleures conditions possibles.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 648","pages":"Pages 27-28"},"PeriodicalIF":0.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144703388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Le glaucome chronique à angle ouvert : traiter précocement pour ralentir l’évolution de la maladie 慢性开角型青光眼：早期治疗减缓疾病进展
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-07-01 DOI: 10.1016/j.actpha.2025.05.022
Damien Malbos (Docteur en pharmacie)
{"title":"Le glaucome chronique à angle ouvert : traiter précocement pour ralentir l’évolution de la maladie","authors":"Damien Malbos (Docteur en pharmacie)","doi":"10.1016/j.actpha.2025.05.022","DOIUrl":"10.1016/j.actpha.2025.05.022","url":null,"abstract":"<div><div>Le glaucome chronique à angle ouvert est une pathologie fréquente qui peut évoluer vers une cécité lorsqu’elle n’est pas traitée. L’officinal peut participer à l’optimisation de sa prise en charge, mais aussi rassurer le patient, l’aider à s’approprier son traitement et l’accompagner au mieux dans son suivi ophtalmologique.</div></div><div><div>Chronic open-angle glaucoma is a frequent pathology which, if left untreated, can lead to blindness. Pharmacists can help optimize treatment, but also reassure patients, help them take ownership of their treatment and support them in their ophthalmological follow-up.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 648","pages":"Pages 12-15"},"PeriodicalIF":0.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144703383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anatomie et physiopathologie de l’œil en relation avec les glaucomes 与青光眼有关的眼睛解剖学和生理病理学
IF 0.1
Actualites Pharmaceutiques Pub Date : 2025-07-01 DOI: 10.1016/j.actpha.2025.05.021
Georges Couleaud (Ophtalmologue)
{"title":"Anatomie et physiopathologie de l’œil en relation avec les glaucomes","authors":"Georges Couleaud (Ophtalmologue)","doi":"10.1016/j.actpha.2025.05.021","DOIUrl":"10.1016/j.actpha.2025.05.021","url":null,"abstract":"<div><div>Le glaucome est une maladie de l’œil associée ou non à une augmentation anormale de la pression intraoculaire, caractérisée par la destruction progressive du nerf optique et l’altération du champ visuel. Connaître les particularités anatomiques, physiologiques et physiopathologiques du globe oculaire permet de mieux comprendre cette pathologie.</div></div><div><div>Glaucoma is an eye disease that may or may not be associated with an abnormal increase in intraocular pressure, characterized by progressive destruction of the optic nerve and impairment of the visual field. Knowing the anatomical, physiological and pathophysiological particularities of the eyeball helps us better understand this pathology.</div></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"64 648","pages":"Pages 8-11"},"PeriodicalIF":0.1,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144703382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信